Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.50
Bid: 1,600.50
Ask: 1,601.00
Change: -166.00 (-9.40%)
Spread: 0.50 (0.031%)
Open: 1,616.50
High: 1,620.00
Low: 1,589.50
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Rolls-Royce Defies Down Market On Restructuring

Thu, 14th Jun 2018 08:47

LONDON (Alliance News) - Stocks in London opened lower on Thursday tracking global counterparts lower, after the US Federal Reserve raised interest rates on Wednesday and pointed to four further rate hikes this year as opposed to three previously expected. The FTSE 100 index was down 0.6%, or 43.42points, at 7,660.29 early Thursday. The mid-cap FTSE 250 index was down 0.7%, 144.65 points, at 21,088.22. The AIM All-Share index was down 0.2% at 1,099.22.The Cboe UK 100 was down 0.6% at 12,993.64, the Cboe UK 250 was down 0.5% at 19,323.91, and the Cboe UK Small Companies was down 0.2% at 12,889.76.On the London Stock Exchange, Rolls-Royce Holdings was the best blue chip performer at the open, up 3.0% after the jet engine maker announced plans to cut around 4,600 corporate and support jobs, predominantly in the UK, as part on a new business restructuring plan to save GBP400 million per annum by end of 2020.Rolls-Royce, which in January announced a plan to separate the business into three different units, expects the new restructuring programme to deliver improved returns, higher margins and increased cash flow.Under the restructuring programme, the company aims to remove corporate management layers, complexity and duplication, including within its core engineering division, and replace a centralised decision and control structure by empowered business units having clearer accountabilities, and decision-making powers.The total cash cost of the restructuring programme is expected to be around GBP500 million, which will be incurred across 2018, 2019 and 2020.Rolls-Royce also said current trading remains in-line with full year expectations set out in March.GlaxoSmithKline was second best performer up 1.0% after the pharmaceutical company said its HIV joint venture ViiV Healthcare reported positive results from its phase III GEMINI study programme. The phase III studies for dolutegravir and lamivudine HIV medicines demonstrated the ability to control HIV, with a two-drug regimen in treatment naive HIV-1 infected adults. ViiV is a joint venture between Glaxo, US drugs giant Pfizer Inc and Japan's Shionogi.The GEMINI studies are part of ViiV Healthcare's clinical trial programme for two-drug regimens that seeks to address long-term toxicity concerns of people living with HIV by reducing the number of medicines used in their treatment, the company said.At the other end of the large cap index, Pearson was the worst blue chip performer down 3.9% after Barclays cut the educational publisher to Underweight from Equal Weight.RELX was down 2.1% after UBS downgraded the Anglo-Dutch business information and events company to Sell from Neutral. The pound was firm against the dollar, quoted at USD1.3394 compared to USD1.3370 at the London equities close Wednesday. In domestic political news, UK Prime Minister Theresa May won a crucial vote late Wednesday against an amendment to her Brexit legislation that would have required her to negotiate Britain's continued access to the EU customs union. Lawmakers in the Commons, parliament's elected main house, voted by 325 to 298 against the amendment, after May promised to seek a new "customs arrangement" in a compromise ahead of the vote. Following a second day of debate on her EU Withdrawal Bill, May also won votes against committing Britain to join the European Economic Area and against seeking full access to the EU single market after Brexit.The US Federal Reserve on Wednesday raised its benchmark interest rate to a range of 1.75 to 2.00%, in line with expectations, as unemployment declines and inflation moves to the desired target.The vote of the Federal Open Market Committee was 8-0.The quarter-of-a-percentage-point hike is the second time this year the Fed has increased the rate and comes as the labour market continues to strengthen and economic activity rises at a solid rate.The Fed signalled further rate raises this year, which could lead to dollar strengthening.In a surprise move, the central bank now projects four interest rate hikes in 2018, rather than three. The Fed also dropped wording about rates being "below levels" in the long run."Information received since the Federal Open Market Committee met in May indicates that the labor market has continued to strengthen and that economic activity has been rising at a solid rate. Job gains have been strong, on average, in recent months, and the unemployment rate has declined," the Fed's statement read."This pretty hawkish statement wasn't enough to prevent the dollar from slipping into the red, the currency falling against the pound, the euro and the yen. That's arguably more to do with the strength of the greenback's performance this year and the long-signalled nature of Wednesday's hike, however, than any real sense of disappointment," said Spreadex analyst Connor Campbell.In the US on Wednesday, Wall Street ended lower, with the Dow Jones Industrial Average down 0.5%, S&P 500 down 0.4% and Nasdaq Composite ending 0.1% down.In US corporate news, cable company Comcast is seeking to pry Twenty-First Century Fox away from The Walt Disney Co, as it made a bid of USD65 billion to thwart Disney's effort to take over the media company on Wednesday. Rupert Murdoch's Fox will have to decide in a board vote on July 10 on which offer it prefers. Disney had previously bid USD52.40 billion for the media wing of Fox, which would not include its news or sports elements, including the flagship Fox News.Comcast has separately announced a pre-conditional all-cash firm offer for the entire issued and to be issued share capital of Sky. Shares in Sky were up 0.4%. Also in focus is the European Central Bank's policy meeting in Riga, Latvia on Thursday, announcing its interest rate decision at 1245 BST. This will be followed by a press conference with ECB President Mario Draghi at 1330 BST."We suspect President Draghi will give a strong hint that the ECB is looking to end the bond-buying programme, but that full details will be provided in the next meeting in July. In the first instance, markets will focus on whether the ECB's forward guidance for the asset purchase programme will be changed," said analysts at Lloyds. In mainland Europe, the CAC 40 in Paris was down 0.5% while the DAX 30 in Frankfurt was down 0.6% early Thursday.The euro was higher quoted at USD1.1802 against USD1.1773 at the European equities close Wednesday. Still to come in the economic calendar are UK and US retail sales data at 0930 BST and 1330 BST respectively. The Japanese Nikkei 225 index closed down 0.8%. In China, the Shanghai Composite closed down 0.2%, while the Hang Seng index in Hong Kong is down 1.1%.Industrial production in China was up 6.8% on year in May, the National Bureau of Statistics said. That was shy of expectations for 7.0%, which would have been unchanged from the April reading. The bureau also said that retail sales were up an annual 8.5% in May - also missing expectations for 9.6% and down from 9.4% in the previous month. Meanwhile, China's central bank retained borrowing costs after the US Fed decided to hike its rate for the second time this year. The People's Bank of China maintained the 7-day reverse repo at 2.55% and the rate on 14-day tenor at 2.70%. The benchmark one-year lending rate has been unchanged since October 2015.
More News
24 Jul 2023 07:07

GSK's ViiV gets Europe nod for HIV prophylaxis

(Sharecast News) - Pharmaceuticals giant GSK announced on Monday that its majority-owned HIV specialist subsidiary ViiV Healthcare has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), recommending marketing authorisation for 'cabotegravir' long-acting (LA) injectable and tablets for HIV prevention.

Read more
22 Jul 2023 18:32

Bavarian Nordic ends RSV vaccine programme after poor trial results

July 22 (Reuters) - Denmark-based Bavarian Nordic said on Saturday it was ending its respiratory syncytial virus (RSV) vaccine programme as its Phase 3 clinical trial did not meet all the primary goals of preventing lower respiratory tract disease.

Read more
14 Jul 2023 09:13

LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
14 Jul 2023 07:56

LONDON BRIEFING: Burberry shines in China; ITV-All3Media deal unlikely

(Alliance News) - Stocks in London are expected to slip into the red at Friday's open, in a tepid conclusion to what has been a largely positive week for global equities, as the market prices in a lower peak for US interest rates.

Read more
13 Jul 2023 16:13

Sensodyne toothpaste-maker Haleon planning job cuts - The Guardian

July 13 (Reuters) - Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and worldwide, the Guardian reported on Thursday.

Read more
10 Jul 2023 09:27

LONDON BROKER RATINGS: HSBC downgrades commercial property stocks

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
6 Jul 2023 15:46

UK dividends calendar - next 7 days

Friday 7 July 
Anglo-Eastern Plantations PLCdividend payment date
Associated British Foods PLCdividend payment date
Blackrock Frontiers Investment Trust PLCdividend payment date
Crystal Amber Fund Ltddividend payment date
Forterra PLCdividend payment date
Hill & Smith PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
LXi REIT PLCdividend payment date
Restore PLCdividend payment date
S&U PLCdividend payment date
Titon Holdings PLCdividend payment date
Victorian Plumbing Group PLCdividend payment date
Warehouse REIT PLCdividend payment date
Whitbread PLCdividend payment date
WPP PLCdividend payment date
Monday 10 July 
Capital Gearing Trust PLCdividend payment date
Great Portland Estates PLCdividend payment date
Tuesday 11 July 
Emis Group PLCdividend payment date
Pets at Home Group PLCdividend payment date
Wednesday 12 July 
Assura PLCdividend payment date
LondonMetric Property PLCdividend payment date
M&C Saatchi PLCdividend payment date
Pharos Energy PLCdividend payment date
Renew Holdings PLCdividend payment date
Thursday 13 July 
BlackRock Latin American Investment Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Caffyns PLCex-dividend payment date
CMC Markets PLCex-dividend payment date
FirstGroup PLCex-dividend payment date
GSK PLCdividend payment date
Halma PLCex-dividend payment date
Invesco Bond Income Plus Ltdex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Record PLCex-dividend payment date
Schroder UK Mid Cap Fund PLCex-dividend payment date
Shoe Zone PLCex-dividend payment date
Sirius Real Estate Ltdex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Triad Group PLCex-dividend payment date
Wincanton PLCex-dividend payment date
XP Power Ltddividend payment date
Young & Co's Brewery PLCdividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
5 Jul 2023 09:34

LONDON BROKER RATINGS: UBS likes Pearson; Liberum cuts Naked Wine

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
4 Jul 2023 10:18

PRESS: Advil owner Haleon to explore sale of nicotine gum business

(Alliance News) - Haleon PLC is exploring a potential divestment of some smoking cessation products, including the Nicotinell brand of nicotine gum, patches and lozenges, according to a Bloomberg report on Tuesday.

Read more
30 Jun 2023 22:38

First trial over Zantac cancer claims set for November

June 30 (Reuters) - The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for plaintiffs in the litigation said Friday.

Read more
29 Jun 2023 06:30

Sanofi says it's back to the drawing board on mRNA flu vaccines

June 29 (Reuters) - Sanofi said that trials show the currently available mRNA technology behind the most successful COVID-19 shots will not be effective against influenza and it is already working on a next generation of shots.

Read more
28 Jun 2023 16:18

GSK completes acquisition of chronic cough-focused Bellus Health

(Alliance News) - GSK PLC on Wednesday said it completed its acquisition of Quebec-based late-stage biopharmaceutical firm Bellus Health Inc for a total equity value of USD2.0 billion.

Read more
27 Jun 2023 08:21

GSK granted US FDA fast track for gonorrhoea vaccine

(Alliance News) - GSK PLC on Tuesday reported that the US Food & Drug Administration has granted its gonorrhoea investigational vaccine a "fast track" designation.

Read more
27 Jun 2023 08:07

GSK gonorrhoea vaccine gets FDA fast track designation

(Sharecast News) - GSK said on Tuesday that its investigational vaccine for sexually transmitted infection gonorrhoea has been granted a fast track designation by the US Food and Drug Administration.

Read more
27 Jun 2023 07:56

LONDON BRIEFING: Stocks called up; record profit for Telecom Plus

(Alliance News) - Stock prices in London were set to open higher on Tuesday, following a positive session for equities in Hong Kong and Shanghai.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.